Protalix BioTherapeutics Inc.

Available to platforms
R StocksTrader
Protalix BioTherapeutics Inc. (Ticker: PLX) is a biopharmaceutical company specializing in the development and production of recombinant therapeutic proteins using its proprietary ProCellEx® plant cell-based protein expression system. The company's lead product, Elelyso® (taliglucerase alfa), is approved for the treatment of Gaucher disease. Protalix is also advancing a pipeline of treatments for other rare diseases, including Fabry disease and cystic fibrosis. Its innovative approach aims to provide cost-effective and scalable therapies for unmet medical needs.

Protalix BioTherapeutics Inc. (PLX) on the NYSE Exchange

Company overview

Protalix BioTherapeutics Inc. is a publicly listed company from USA with shares traded on NYSE under the ticker PLX. This page provides a live view of market pricing and an interactive chart to follow short and long-term moves without manual refresh. The latest streaming quotes for PLX are bid 1.77 USD and ask 1.82 USD.

Use the chart to review recent momentum, identify key price areas, and track how Protalix BioTherapeutics Inc. is performing relative to your portfolio in 2025. If you are researching the instrument for trading or investing, add PLX to your watchlist in R StocksTrader and compare it with other US and European shares, indices, and metals.

Key facts

  • Exchange: NYSE
  • Company: Protalix BioTherapeutics Inc.
  • Ticker: PLX
  • Country: USA
  • Bid1.77 USD
  • Ask1.82 USD
  • Quotes: real-time, auto-updated

Risk

Risk Warning: Past performance of PLX does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy, and then place an order for Protalix BioTherapeutics Inc. (PLX) in R StocksTrader. Create and verify your profile, fund the account, search for PLX, and choose the instrument type available to you. Add PLX to your Watchlist to track moves and manage open positions throughout 2025.

PLX trades on NYSE and is issued by Protalix BioTherapeutics Inc.. This page provides a live chart and continuously updated price data for the 2025 year so that you can follow intraday swings and longer trends. Before starting trading and placing orders, review trading hours, typical spreads, and fees in the terminal to make sure conditions for PLX match your plan.

Quotes update automatically in real time. Current levels for PLX are bid 1.77 USD and ask 1.82 USD. The spread is the difference between ask and bid and affects your effective entry and exit. Track PLX in R StocksTrader and adjust your approach as market conditions change in 2025.